Completed NA INTERVENTIONAL 3-arm NCT03054779

Canola Oil Multi-center Intervention Trial II (COMITII)

Canola Oil Multi-center Intervention Trial II (COMIT II): Effects of Oleic Acid Enriched and Regular Canola Oil on Body Composition and Lipid Metabolism in Participants With Metabolic Syndrome Risk Factors

Sponsor: Canola Council of Canada

Conditions Cardiovascular Disease Metabolic Syndrome

Interventions Canola Oil High oleic acid canola oil Western diet oil combination

Updated 8 times since 2017 Last updated: Aug 16, 2023 Started: Sep 30, 2014 Primary completion: Nov 30, 2016 Completion: Nov 30, 2016

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT03054779, this NA trial focuses on Cardiovascular Disease and Metabolic Syndrome and remains completed. Sponsored by Canola Council of Canada, it has been updated 8 times since 2014, reflecting limited change activity. This study contributes longitudinal data to the cardiovascular research landscape.

Status Flow

Change History

8 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Sep 2023 — Jul 2024 [monthly]

Completed NA
Oct 2021 — Sep 2023 [monthly]

Completed NA
Jan 2021 — Oct 2021 [monthly]

Completed NA

▶ Show 3 earlier versions

Oct 2020 — Jan 2021 [monthly]

Completed NA
Jun 2018 — Oct 2020 [monthly]

Completed NA
Feb 2017 — Jun 2018 [monthly]

Completed NA

First recorded

Sep 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Canola Council of Canada
Laval University
Penn State University
St. Boniface Hospital
Unity Health Toronto
University of Manitoba

Data source: Penn State University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• University Park, United States